HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

DOTA- beta- Ala(3)- Nle(4)- Asp(5)- Phe(7)- Lys(10)- (111)indium-alpha-MSH (3-10)

structure in first source
Also Known As:
(111)indium-alpha-MSH (3-10), DOTA-beta-Ala(3)-Nle(4)-Asp(5)-Phe(7)-Lys(10)-; 111In-DOTA-3-beta-Ala-4-Nle-5-Asp-7-Phe-10-Lys-alpha-MHS(3-10); 111In-alpha-MSH (3-10)-DOTA-beta-alanyl(3)-norleucyl(4)-aspartyl(5)-phenylalanyl(7)-lysyl(10)-; DOTA-MSH(oct)
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Froidevaux, Sylvie: 3 articles (09/2003 - 12/2002)
2. Eberle, Alex N: 3 articles (09/2003 - 12/2002)
3. Tanner, Heidi: 2 articles (06/2003 - 12/2002)
4. Calame-Christe, Martine: 2 articles (06/2003 - 12/2002)
5. Sumanovski, Lazar: 2 articles (06/2003 - 12/2002)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. Melanocyte-Stimulating Hormones (MSH)
2. 4-Nle-7-Phe-alpha- MSH